Cargando…

Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice

INTRODUCTION: Antidrug antibody (ADA) production may be the reason behind secondary inefficacy of anti-TNF-α therapy in psoriasis. AIM: To investigate the production of ADA, serum tumor necrosis factor α (TNF-α) and drug levels as predictors of clinical response in real-life circumstances. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herszényi, Krisztina, Jókai, Hajnalka, Rencz, Fanni, Brodszky, Valentin, Nagy, Eszter, Holló, Péter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906958/ https://www.ncbi.nlm.nih.gov/pubmed/31839776 http://dx.doi.org/10.5114/ada.2019.89507

Ejemplares similares

Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters
por: Piros, Éva Anna, et al.
Publicado: (2021)

Impact of Interleukin-17 Inhibitor Therapy on Arterial Intima-media Thickness among Severe Psoriatic Patients
por: Piros, Éva Anna, et al.
Publicado: (2021)

Is the trend of increasing use of patient-reported outcome measures in medical device studies the sign of shift towards value-based purchasing in Europe?
por: Weszl, Miklós, et al.
Publicado: (2019)

Assessment of health state utilities in dermatology: an experimental time trade-off value set for the dermatology life quality index
por: Ruzsa, Gábor, et al.
Publicado: (2022)

Patient and general population values for luminal and perianal fistulising Crohn’s disease health states
por: Rencz, Fanni, et al.
Publicado: (2019)

Measurement properties of the ICECAP-A capability well-being instrument among dermatological patients
por: Rencz, Fanni, et al.
Publicado: (2021)

A head-to-head comparison of the EQ-5D-5L and 15D descriptive systems and index values in a general population sample
por: Nikl, Anna, et al.
Publicado: (2023)

The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017)

Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017)

The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate
por: Mojtahed Poor, Sorwe, et al.
Publicado: (2023)

Anti-PD-1 Monotherapy in Advanced Melanoma—Real-World Data from a 77-Month-Long Retrospective Observational Study
por: Kuzmanovszki, Daniella, et al.
Publicado: (2022)

Hungarian PROMIS-29+2: psychometric properties and population reference values
por: Jenei, Balázs, et al.
Publicado: (2023)

Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies
por: Bitoun, Samuel, et al.
Publicado: (2023)

Validity and reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in a national survey in Hungary
por: Rencz, Fanni, et al.
Publicado: (2019)

Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Health utilities and willingness to pay in adult patients with coeliac disease in Hungary
por: Angyal, M. Mercédesz, et al.
Publicado: (2023)

Value Set for the EQ-5D-Y-3L in Hungary
por: Rencz, Fanni, et al.
Publicado: (2022)

General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic
por: Koszorú, Kamilla, et al.
Publicado: (2022)

Societal costs and health related quality of life in adult atopic dermatitis
por: Beretzky, Zsuzsanna, et al.
Publicado: (2023)

Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection
por: Eser, Alexander, et al.
Publicado: (2020)

Real-World Experience with Cemiplimab Treatment for Advanced Cutaneous Squamous Cell Carcinoma—A Retrospective Single-Center Study
por: Kuzmanovszki, Daniella, et al.
Publicado: (2023)

Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis
por: Koszorú, Kamilla, et al.
Publicado: (2022)

A Rasch model analysis of two interpretations of ‘not relevant’ responses on the Dermatology Life Quality Index (DLQI)
por: Rencz, Fanni, et al.
Publicado: (2021)

Subjective well-being in patients with pemphigus: a path analysis
por: Mitev, Ariel, et al.
Publicado: (2019)

Capability of well-being: validation of the Hungarian version of the ICECAP-A and ICECAP-O questionnaires and population normative data
por: Baji, Petra, et al.
Publicado: (2020)

Therapeutic Protein PEPylation: The Helix of Nonfouling Synthetic Polypeptides Minimizes Antidrug Antibody Generation
por: Hou, Yingqin, et al.
Publicado: (2019)

Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis
por: Jani, Meghna, et al.
Publicado: (2015)

Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
por: Benucci, Maurizio, et al.
Publicado: (2018)

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data
por: Brodszky, Valentin, et al.
Publicado: (2017)

Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary
por: Péntek, Márta, et al.
Publicado: (2019)

Acceptable health and ageing: results of a cross-sectional study from Hungary
por: Péntek, Márta, et al.
Publicado: (2020)

Pharmacokinetic Effects of Antidrug Antibodies Occurring in Healthy Subjects After a Single Dose of Intravenous Infliximab
por: Ehrenpreis, Eli D.
Publicado: (2017)

Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision
por: Adair, Patrick R., et al.
Publicado: (2017)

Impact of glycoengineering and antidrug antibodies on the anticancer activity of a plant‐made lectin‐Fc fusion protein
por: Dent, Matthew, et al.
Publicado: (2022)

Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove
por: Tsakok, Teresa, et al.
Publicado: (2023)

The prevalence of ADH1B and OPRM1 alleles predisposing for alcohol consumption are increased in the Hungarian psoriasis population
por: Szentkereszty-Kovács, Zita, et al.
Publicado: (2019)

Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma
por: Kim, Chan, et al.
Publicado: (2022)

A machine learning approach for identifying variables associated with risk of developing neutralizing antidrug antibodies to factor VIII
por: Rawal, Atul, et al.
Publicado: (2023)

Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
por: Péntek, Márta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e6fn4823a9jn7fir1ssia7pquq